Skip to main content
Industry News
Lilly supports Jaguar in funding round
4/15/2021

Eli Lilly and Co. was one of the supporters that helped raise $139 million for Jaguar Gene Therapy in a Series B funding round. Jaguar is developing preclinical gene therapies that target galactosemia, type 1 diabetes and gene-linked autism.

Full Story: